A 52 Week High for Biogen Idec, will it Hold?

biib New York, April 4th (TradersHuddle.com) - Shares of Biogen Idec Inc. (NASDAQ:BIIB) booked a new 52 week high today by trading above $128.87, traders are definitely monitoring Biogen's price action to see if this move attracts further buying into the stock.

Biogen Idec Inc. (NASDAQ:BIIB) develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The products from the biotechnology company addresses diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, crohn's disease, and psoriasis. The company was founded in 1985 and is based in

Biogen Idec is currently trading 0.36% versus its previous trading session close, and it has calculated support and resistance at $116.44 and $127.85 respectively. Clearly, with this action this range has been penetrated, and traders will be reviewing price action to establish a new tradable range.

The overall market index S&P 500 is trading lower by -1.18% from its previous trading close, which means that Biogen Idec stock is outperforming the overall market.

TradersHuddle Search

Stock Search:

Site Search:


Recent Trading Ideas

Latest Partner Headlines

Stock Market

o Dow Jones 17,734.56 ▲115.05 (0.65%)
o S&P 500 2,076.19 ▲13.08 (0.63%)
o NASDAQ 5,019.70 ▲32.83 (0.66%)

Dow Jones

Company ID [INDEXDJX:.DJI] Last trade:17,734.56 Trade time:11:09AM EDT Value change:▲115.05 (0.65%)

S&P 500

Company ID [INDEXSP:.INX] Last trade:2,076.19 Trade time:11:09AM EDT Value change:▲13.08 (0.63%)


Company ID [INDEXNASDAQ:.IXIC] Last trade:5,019.70 Trade time:11:09AM EDT Value change:▲32.83 (0.66%)
Copyright © 2013 TradersHuddle.com. All Rights Reserved.